Company Filing History:
Years Active: 2011-2013
Title: The Innovations of Robert Letienne
Introduction
Robert Letienne is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antagonists for protease-activated receptor-1 (PAR-1). With a total of 3 patents to his name, Letienne's work is recognized for its potential impact on the treatment of thrombosis.
Latest Patents
Letienne's latest patents include innovative compounds known as cinnamoyl-piperazine derivatives. These compounds are designed to act as PAR-1 antagonists, which are particularly useful in the treatment of thrombosis. The present invention relates to compounds of general formula (I), which have shown promise in medical applications.
Career Highlights
Throughout his career, Robert Letienne has been associated with Pierre Fabre Medicament, a company known for its commitment to research and development in the pharmaceutical sector. His work has contributed to advancements in therapeutic options for patients suffering from thrombotic conditions.
Collaborations
Letienne has collaborated with esteemed colleagues such as Michel Perez and Marie Lamothe. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking medical solutions.
Conclusion
Robert Letienne's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, particularly in the area of thrombosis.